Back to Journals » Clinical and Experimental Gastroenterology » Volume 3

Review

Imatinib as the first and only treatment in Europe for adult patients at significant risk of relapse following gastrointestinal stromal tumor removal

         
Total article views   Abstract views HTML views PDF downloads Totals
5,505 Dovepress* 5,505 0+ 2,091 5,505
Totals 5,505 0 2,091 5,505
*Since 12 May 2010
+Since July 2016

View citations on Google Scholar